Difference between revisions of "DBP2:Main"
From NAMIC Wiki
| (5 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
Back to [[Cores|NA-MIC Cores]] | Back to [[Cores|NA-MIC Cores]] | ||
__NOTOC__ | __NOTOC__ | ||
| − | {| style="background:# | + | {| style="background:#888" cellspacing="2" align="right" |
| | | | ||
| − | {| style="background:# | + | {| style="background:#ddd" |
|colspan="2" align="center"|<b>Featured Article</b> | |colspan="2" align="center"|<b>Featured Article</b> | ||
|- | |- | ||
| − | |width=" | + | |width="250px" valign="top"|[[Image:ProstateDiagram.png|200px|]] |
<br/> | <br/> | ||
[[DPB2:Past_Featured_Articles|Past featured articles]] | [[DPB2:Past_Featured_Articles|Past featured articles]] | ||
| − | |align="left" width=" | + | |align="left" width="350px"|Gabor Fichtinger, Jonathan Fiene, Christopher W. Kennedy, Gernot Kronreif, Iulian I. Iordachita, Danny Y. Song, E. Clif Burdette, and Peter Kazanzides. |
[[Media:Gabor-robotic07.pdf|Robotic Assistance for Ultrasound Guided Prostate Brachytherapy]]. | [[Media:Gabor-robotic07.pdf|Robotic Assistance for Ultrasound Guided Prostate Brachytherapy]]. | ||
| − | + | Med Image Anal. 2008 Oct;12(5):535-45. | |
| − | [[DPB2:Past_Featured_Articles|Abstract]] | + | [[DPB2:Past_Featured_Articles#fichtinger_miccai_07|Abstract]] |
|} | |} | ||
|} | |} | ||
| Line 22: | Line 22: | ||
The NA-MIC Driving Biological Problems (DBP) Core 3.2 identifies key biological problems to drive NA-MIC projects from 2007 to 2010. From the beginning of the NCBC project, NIH planned for a three year cycle for the DBPs. In accordance with this policy, in 2007 the DBPs were shifted from schizophrenia to lupus, autism, velocardiofacial syndrome (VCSF), and prostate cancer. The process of selecting these DBPs is detailed [[DBP2:Selection|here]]. | The NA-MIC Driving Biological Problems (DBP) Core 3.2 identifies key biological problems to drive NA-MIC projects from 2007 to 2010. From the beginning of the NCBC project, NIH planned for a three year cycle for the DBPs. In accordance with this policy, in 2007 the DBPs were shifted from schizophrenia to lupus, autism, velocardiofacial syndrome (VCSF), and prostate cancer. The process of selecting these DBPs is detailed [[DBP2:Selection|here]]. | ||
| + | |||
| + | =DBP2 Final Reports= | ||
| + | * '''Due by end of October 2010''' | ||
| + | * [[DBP2:HarvardFinal:2010|Harvard: Final Report]] | ||
| + | * [[DBP2:MINDFinal:2010|MIND: Final Report]] | ||
| + | * [[DBP2:QueensFinal:2010|Queens: Final Report]] | ||
| + | * [[DBP2:UNCFinal:2010|UNC: Final Report]] | ||
= DBP 2 Projects - Organized by Site = | = DBP 2 Projects - Organized by Site = | ||
| + | |||
* [[DBP2:Harvard|Harvard: Velocardiofacial Syndrome (VCFS) as a Genetic Model for Schizophrenia]] | * [[DBP2:Harvard|Harvard: Velocardiofacial Syndrome (VCFS) as a Genetic Model for Schizophrenia]] | ||
Latest revision as of 15:06, 14 September 2010
Home < DBP2:MainBack to NA-MIC Cores
| ||||
DBP 2 Overview
The NA-MIC Driving Biological Problems (DBP) Core 3.2 identifies key biological problems to drive NA-MIC projects from 2007 to 2010. From the beginning of the NCBC project, NIH planned for a three year cycle for the DBPs. In accordance with this policy, in 2007 the DBPs were shifted from schizophrenia to lupus, autism, velocardiofacial syndrome (VCSF), and prostate cancer. The process of selecting these DBPs is detailed here.
DBP2 Final Reports
- Due by end of October 2010
- Harvard: Final Report
- MIND: Final Report
- Queens: Final Report
- UNC: Final Report
DBP 2 Projects - Organized by Site
- Harvard: Velocardiofacial Syndrome (VCFS) as a Genetic Model for Schizophrenia
- MIND: The Analysis of Brain Lesions in Neuropsychiatric Systemic Lupus Erythematosus
- Queens: Image-Guided Percutaneous Surgery
- UNC: Longitudinal MRI study of early brain development in neuropsychiatric disorder: UNC Autism Study
